Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis-inducing pathways" refers to the network of molecular signals that activate programmed cell death in response to various internal and external cues. These pathways are broadly divided into the intrinsic (mitochondrial) and extrinsic (death receptor-mediated) mechanisms. The intrinsic pathway is controlled by the balance of pro- and anti-apoptotic Bcl-2 family proteins and mitochondrial events, while the extrinsic pathway involves ligand-induced activation of cell surface death receptors leading to caspase activation. Both routes converge at the execution phase, marked by activation of executioner caspases that orchestrate cell destruction. Dysregulation of apoptosis-inducing pathways is central to the pathogenesis of various diseases, especially cancer, making individual pathway components key drug targets for therapeutic intervention[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis-inducing pathway.